by ISHLT
ISHLT Voices features conversations, studies, and member profiles. Explore advanced heart and lung failure, transplantation, mechanical circulatory support, and pulmonary vascular disease through the eyes of your community. The content of industry-supported ISHLT Voices podcasts are developed entirely by our industry partners. They are not official ISHLT educational programs, and therefore are not eligible for CME under the ISHLT.
Language
🇺🇲
Publishing Since
7/12/2022
See how your podcast performs across key metrics
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
June 24, 2026
<p class="MsoNormal">In this episode of the ISHLT Voices podcast, hosted by Kamada, you'll hear experts discuss different cytomegalovirus (CMV) prophylaxis approaches in high-risk lung transplant patients.</p> <p class="MsoNormal"> </p> <p class="MsoNormal"><strong><img src= "//assets.libsyn.com/show/423830/Fernando-Torres-Headshot-Square.png" alt="" width="150" height="150" align="left" hspace="6" />Fernando Torres, MD</strong></p> <p class="MsoNormal"> </p> <p class="MsoNormal">Professor of Internal Medicine<br /> Clinical Chief, Division of Pulmonary/Critical Care<br /> UT Southwestern Medical Center<br /> <span lang="ES-MX" style="mso-ansi-language: ES-MX;" xml:lang= "ES-MX">Dallas, TX USA</span></p> <p class="MsoNormal"><span lang="ES-MX" style= "mso-ansi-language: ES-MX;" xml:lang="ES-MX"> </span></p> <p class="MsoNormal"><strong><span lang="ES-MX" style= "mso-ansi-language: ES-MX;" xml:lang="ES-MX"><img src= "//assets.libsyn.com/show/423830/Amir-Emtiazjoo-Headshot-Square.png" alt="" width="150" height="150" align="left" hspace="6" />Amir M. Emtiazjoo, MD, MSc</span></strong></p> <p class="MsoNormal"> </p> <p class="MsoNormal">Associate Professor of Medicine<br /> Medical Director, Division of Pulmonary, Critical Care & Sleep Medicine<br /> University of Florida<br /> Gainesville, FL USA</p> <p class="MsoNormal"> </p> <p class="MsoNormal">The discussion is focused on real-world, long-term follow-up data published in 2025 by UT Southwestern. The conversation explores clinical rationale and center practices, highlighting data showing improved survival outcomes in high-risk patients. This episode aims to translate emerging evidence into practical insights for transplant clinicians.</p> <p class="MsoNormal">The content of this podcast was developed entirely by our industry partner, Kamada. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.</p> <p class="MsoNormal" style="text-align: center;" align="center"> <strong>This episode was created for ISHLT Voices and sponsored by Kamada.</strong></p> <p class="MsoNormal" style="text-align: center;" align="center"> <a href="https://www.kamada.com/" target="_blank" rel= "noopener"><strong><img src= "//assets.libsyn.com/show/423830/Kamada-Logo.png" alt= "Kamada company logo with the tagline Each Life is Unique" width= "309" height="117" /></strong></a></p>
June 26, 2025
Transplant cardiologists Brent Lampert and Ajith P. Nair examine noninvasive molecular diagnostics like Natera’s Prospera Heart with Donor Quantity Score for improved heart transplant monitoring in this interview.
November 14, 2024
<p class="MsoNormal">In this episode of the ISHLT Voices podcast, hosted by <a href= "https://www.natera.com/organ-health/prospera-lung-transplantation-assessment/?utm_source=ishlt&utm_campaign=ishltpodcast&utm_medium=promotion#slam" target="_blank" rel="noopener"><strong>Natera</strong></a>, you’ll hear a discussion on the need for noninvasive surveillance options for single lung transplantation and the role that the Prospera Lung donor derived cell free DNA (dd-cfDNA) test can play.</p> <p class="MsoNormal">There are inherent, increased risks and challenges associated with management of single lung transplantation over double lung. Monitoring through invasive transbronchial biopsy procedures (TBBx) is often not the best option for these high-risk, frail patients.</p> <p class="MsoNormal">In this podcast, notable transplant pulmonologists Drs. Rosenheck and Arunachalam highlight the need in the single lung population for noninvasive surveillance options. The Prospera Lung donor derived cell free DNA (dd-cfDNA) test has been validated in single and double lung transplants with emerging data in support of clinical utility. The expert speakers also discuss the recently published data in support of dd-cfDNA usage in the single lung transplant population from the SLAM study. </p> <p class="MsoNormal"><strong>Justin Rosenheck, DO<br /></strong>Assistant Professor of Internal Medicine<br /> Ohio State University | Columbus, OH USA</p> <p class="MsoNormal"><strong>Ambalavanan Arunachalam, MD<br /></strong>Assistant Professor, Medicine (Pulmonary and Critical Care)<br /> Northwestern Medicine | Chicago, IL USA</p> <p class="MsoNormal" style="text-align: center;" align="center"> <em>The content of this podcast was developed entirely by ISHLT's industry partner, Natera. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.</em></p> <p class="MsoNormal" style="text-align: center;" align="center"> <a href= "https://www.natera.com/organ-health/prospera-lung-transplantation-assessment/?utm_source=ishlt&utm_campaign=ishltpodcast&utm_medium=promotion#slam" target="_blank" rel="noopener"><em><img src= "//assets.libsyn.com/show/423830/Natera_Logo.png" alt="" width= "600" height="121" /></em></a></p>
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Brent Lampert
Guest
Ajith P Nair
Guest
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
ISHLT Voices features conversations, studies, and member profiles. Explore advanced heart and lung failure, transplantation, mechanical circulatory support, and pulmonary vascular disease through the eyes of your community.
The content of industry-supported ISHLT Voices podcasts are developed entirely by our industry partners. They are not official ISHLT educational programs, and therefore are not eligible for CME under the ISHLT.
This podcast updates weekly.
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Yes, this podcast regularly features guests.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.